Onderzoeker
Lisa Kinget
- Disciplines:Kankerbiologie, Kankerdiagnose, Kankertherapie
Affiliaties
- Laboratorium Experimentele Oncologie (Afdeling)
Lid
Vanaf1 okt 2020 → Heden
Projecten
1 - 1 of 1
- Predictieve biomerkers bij het gemetastaseerde heldercellige niercarcinoom behandeld met bloedvatremmers en/of immuun checkpoint inhibitorenVanaf1 okt 2020 → HedenFinanciering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
Publicaties
1 - 10 van 15
- Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.(2024)
Auteurs: Lisa Kinget
Pagina's: 86 - Trial watch: chemotherapy-induced immunogenic cell death in oncology(2023)
Auteurs: Jenny Sprooten, Isaure Vanmeerbeek, Stefan Naulaerts, Lisa Kinget, An Coosemans, Steven De Vleeschouwer, Els Wauters, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, et al.
- Multi-omics mapping positions antigenic myeloid-T cell crosstalk at the core of advanced renal cell carcinoma (aRCC) response to immune checkpoint blockade (ICB)(2023)
Auteurs: Lisa Kinget, Isaure Vanmeerbeek, Diether Lambrechts, Bram Boeckx, Maarten Albersen, Sabine Tejpar, Benoit Beuselinck, Abhishek Garg
Pagina's: S1026 - S1027 - Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma(2023)
Auteurs: Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel
- Trial watch: Dendritic cell (DC)-based immunotherapy for cancer(2022)
Auteurs: Jenny Sprooten, Stefan Naulaerts, Benoit Beuselinck, An Coosemans, Lisa Kinget, Sandra Tuyaerts, Steven De Vleeschouwer, Abhishek Garg
- Clearseq1-4 classifier in localized and metastatic clear-cell renal cell carcinoma (ccRCC)(2022)
Auteurs: Lisa Kinget, Diether Lambrechts, Bram Boeckx, Maarten Albersen, Benoit Beuselinck
Pagina's: S1222 - S1223 - Molecular Heterogeneity Between Paired Primary and Metastatic Lesions from Clear Cell Renal Cell Carcinoma(2022)
Auteurs: Eduard Roussel, Lisa Kinget, Bram Boeckx, Steven Joniau, Diether Lambrechts, Maarten Albersen, Benoit Beuselinck
Pagina's: 54 - 57 - Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study(2022)
Auteurs: Annouschka Laenen, Marcella Baldewijns, Herlinde Dumez, Paul Clement, Hans Wildiers, Patrick Schöffski, Eduard Roussel, Lisa Kinget, Maarten Albersen, Benoit Beuselinck
Pagina's: 22 - 29 - Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant Trials(2021)
Auteurs: Eduard Roussel, Lisa Kinget, Bram Boeckx, Marcella Baldewijns, Hendrik Van Poppel, Steven Joniau, Diether Lambrechts, Maarten Albersen, Benoit Beuselinck
Pagina's: 1 - 13 - Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications(2021)
Auteurs: Eduard Roussel, Lisa Kinget, Bram Boeckx, Marcella Baldewijns, Steven Joniau, Hendrik Van Poppel, Diether Lambrechts, Maarten Albersen, Benoit Beuselinck
Pagina's: 1499 - 1506